Autopsy report · NCT06405061

Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma

“Mid-term data analysis for the project has been completed; enrollment is now suspended.”

The sponsor’s own words in the registry.

Life of this trial

• Suspended: paused, and may or may not restart.
• 40 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 2

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Sponsor type

University, hospital or other

Conditions

Adebrelimab; Hepatocellular Carcinoma

Interventions

Adebrelimab

Participants

40 (planned, not actual)

Sites

4

Countries

China

Trials that died the same way

• Angiotensin (1-7) Treatment to Improve Cognitive Functioning in Heart Failure Patients
  “Study Suspended. Slow enrollment.” (72% match in meaning)
• Emory Latino Diabetes Education Program
  “Enrollment and study activities were suspended in March 2020 due to the COVID-19 pandemic and re-opening the study was delayed pending additional funding. The study was ultimately terminated in January of 2026 due to lack of funding.” (69% match in meaning)
• An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms
  “Enrollment/study activities have been temporarily suspended while the sponsor evaluates internal study priorities and resource allocation. The suspension is not related to participant safety, protocol compliance, data quality, or regulatory concerns.” (68% match in meaning)
• Premotor Cortex: A New Target for Stroke Motor Rehabilitation
  “Study was suspended pending additional funding to continue participant recruitment and was ultimately terminated in 2024.” (67% match in meaning)
• Heliox-Powered Albuterol Therapy in the Treatment of Children Admitted With Acute Asthma Exacerbation
  “Study was stopped after interim analysis and slow enrollment.” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.